IPO Boutique

Avedro, Inc IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Avedro, Inc, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Avedro, IncAVDR -
NASDAQ
$14.00-$16.00 $14.00 $11.595 million2/14/2019
BofA Merrill Lynch, JP Morgan, Cowen, Guggenheim Securities, SVB Leerink
Co-Manager(s):
Health Care
Filing(s):

Filed 2019-01-18
Terms Added 2019-02-04



Avedro, Inc Quote & Chart - Click for current quote - AVDR

About Avedro, Inc (adapted from Avedro, Inc prospectus):
They are a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "AVDR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved